Diagnostic tests commonly are characterized by their true positive (sensitivity) and true negative (specificity) classification rates, which rely on a single decision threshold to classify a test result as positive. A more complete description of test accuracy is given by the receiver operating characteristic (ROC) curve, a graph of the false positive and true positive rates obtained as the decision threshold is varied. A generalized regression methodology, which uses a class of ordinal regression models to estimate smoothed ROC curves has been described. Data from a multi-institutional study comparing the accuracy of magnetic resonance (MR) imaging with computed tomography (CT) in detecting liver metastases, which are ideally suited for ROC regression analysis, are described. The general regression model is introduced and an estimate for the area under the ROC curve and its standard error using parameters of the ordinal regression model is given. An analysis of the liver data that highlights the utility of the methodology in parsimoniously adjusting comparisons for covariates is presented. -Environ Health Perspect 1 02(Suppl 8): 73-78 (1994) 
Introduction
For a diagnostic modality, the receiver operating characteristic (ROC) curve presents a varied graphic display of all true positive and false positive rate pairs obtained as the decision threshold used to classify a group of diseased and nondiseased subjects as positive (i.e., having disease). Because the ROC curve depicts test performance across all decision thresholds, it is a more general measure of diagnostic performance than sensitivity (true positive rate) and specificity (true negative rate), which rely on a single threshold. Metz (1) reviewed the use of ROC curve analysis in the radiologic literature.
Smoothed ROC curve estimation is usually completed using a model from signal detection theory, which assumes the existence of an unobserved scale along which responses are distributed. The most widely used model, detailed by Green and Swets (2) , assumes that the responses (or some monotonic transformation of them) are distributed according to a normal density function with the parameters of the density function differing according to true disease status (e.g., N(u0, ac) for nondiseased patients and distribution N(Qu1, i ) for diseased patients). Under this model, estimation of ROC curve parameters is accomplished using a maximum likelihood algorithm developed by Dorfman and Alf (3) . Swets and Pickett (4) discuss in detail the uses of the Dorfman and Alf methodology for the analysis of diagnostic systems.
The primary limitation of the Dorfman and Alf approach is the difficulty that occurs when covariates must be considered in the analysis. Because the signal detection model provides no facility for incorporating covariates directly into the analysis, one must form subgroups and estimate ROC curves separately in each. This approach precludes the consideration of continuous covariates and often becomes impractical because of sparse data. The need to accommodate covariates is exemplified by data from the liver protocol of the magnetic resonance imaging (MR) collaborative working group*, which was designed to compare MR at several magnet field strengths with dynamic, enhanced computed tomography (CT) in the detection of liver metastases in patients with primary malignancies of the breast, colon, lung, and pancreas. Among the factors that may influence the accuracy of MR and CT and that must be considered in the analysis are patient-specific covariates such as primary tumor site, modality-specific covariates such as magnet field strength, and external covariates such as reviewer.
Recently, Tosteson and Begg (5) described an approach to ROC curve estimation which includes the Dorfman and Alf model as a special case of a much more general class of models. To estimate ROC curve parameters from rating experiment data, the general regression approach uses one of a class of ordinal regression models developed by McCullagh (6).
*The magnetic resonance imaging collaborative working group was comprised of radiologists from Bowman-Gray School of Medicine, Cleveland Clinics, Duke University, Massachusetts General Hospital, and the University of California at San Francisco. This group was formed to assess the diagnostic accuracy of MR in the detection and characterization of disease at seven skeletal sites in comparison to the currently used standard modality (or modalities) at each disease site.
Environmental Health Perspectives
In this article, our goal is to illustrate how ROC regression analysis facilitates diagnostic test assessment. We first present a detailed description of issues in the analysis of data from the multi-institutional liver protocol. Next we introduce the ordinal regression model and use its parameters to give an estimate for the commonly used ROC curve summary statistic, the area under the curve, and its standard error. A detailed analysis of the liver protocol data is presented.
The Liver Protocol
In patients with cancer, it is important for patient management that the disease be followed closely and that the presence or absence of hepatic metastases be correctly diagnosed. To determine which modality is most accurate in the diagnosis of metastases the MR collaborative working group collected data according to the liver protocol described here.
Consecutive patients who were referred for investigation of possible liver metastases, or who had histologically documented liver metastases and had documentation ( 
The Rating Experiment
Prior to the documentation of true disease status the CT, MR pairs for each subject were sent from each institution to a central review meeting. The central review process consisted of a rating experiment in which one radiologist from each institution participated.
The reviews were generally carried out over a 2-day period during which the five radiologists (reviewers) participated in four review sessions. For each radiologist a review session consisted of rating a batch of 20 to 40 CT scans or MR images. The review was designed so that each subject received two independent ratings of both their CT scan and MR image.
Reviewers were blinded to patient history and all patient characteristics except for primary tumor site. Primary tumor site was made available to the reviewing radiologists because it was judged that omission of this critical information would hamper the radiologists' review of both modalities and would therefore not fairly represent either modality as used in clinical practice.
In keeping with the blinded review process, reviewers were not allowed to rate examinations from their own institution, because their interpretation of MR and CT for these cases could be influenced by their knowledge of the patient's subsequent clinical course. In addition, with two exceptions (i.e., two sessions, one batch in each), no reviewer rated the CT, MR pair from an individual subject. These steps were taken in an effort to minimize bias in test interpretation (7, 8) . For example, if a reviewer was first to read the MR images for a group of subjects and later to read their CT scans, the ratings for the CT scans could be influenced by the reviewer's recall of the MR images. This could cause the CT ratings to appear more accurate than they would have been if rated independently, thus biasing the comparison of MR and CT.
The radiologists had been familiarized with the data form used in the rating experiment prior to the review, and were asked to give the likelihood on a scale from 0 to 100 that liver metastases were present.
Issues in the Data Analysis
The primary goal of the data analysis is to compare MR with CT in the detection of liver metastases. The liver data include images from five institutions, which operate MR units at four separate magnet field strengths, and afford a unique opportunity to assess the comparability of MR at each field strength with CT. In making these comparisons, we are concerned with factors that may influence either the accuracy of the modality under study or the manner in which it is interpreted. As outlined below, we consider three classes of factors: patient specific, modality specific, and external.
Patient-specific factors refer to particular patient and disease characteristics that may influence the accuracy of MR or CT or its interpretation. Some questions that we address are the following: Does primary tumor site (or age, gender, etc.) influence the criteria that reviewers used for assigning likelihoods of metastases to subjects? Alternatively, can any apparent differences between MR at varying magnet strengths and CT be explained by confounding due to patient and disease characteristics? The latter is important because, although the paired design of the protocol ensures balance of patient characteristics for the overall MR/CT comparison, this balance is not ensured for the comparisons between MR units using different magnet strengths and CT, because magnet field strengths differ across sites.
Modality-specific factors refer to characteristics of the modality that could influence its accuracy or interpretation, such as magnet field strength and the study year in which the examination was performed. Here we ask, does magnet field strength affect the accuracy of MR? Has there been a change in MR or CT over the three years in which the study was conducted due to modifications in the technology or due to improvements in the reviewers' interpretation of MR?
External factors encompass additional features of the study design that could confound the MR/CT comparisons. The effect that the reviewer has on the accuracy of MR and CT is of particular interest here. We ask: What is the nature of interobserver variability? Are some reviewers better than others or do all reviewers operate along the same ROC curve? The answers to these questions are of intrinsic interest and have strong implications for the comparison between MR and CT.
Although some of the issues discussed here could be accommodated by taking advantage of the paired design and limiting the analysis to a comparison of MR and CT within each site, doing so would result in a loss of power. Furthermore, because no reviewer read both the CT and MR of the same subject, the paired comparisons might be confounded by reviewer effects. Thus, the MR/CT comparison is ideally suited to a regression approach that allows us to control potential confounders. In the The Area Under the ROC Curve
The area under the ROC curve, which is related to the Wilcoxon or Mann-Whitney statistic (10), has become a commonly used summary measure in ROC curve analyses (11, 12) . Although this measure is global and not ideal in settings were ROC curves cross, we present an estimate for the area under the ROC curve using parameters derived from Equation 1 for completeness.
The area under any ROC curve is easily obtained from the estimated parameters a and ,, using the notation and equations detailed below. Let X= (X1,X*), where X1 represents true disease status and X* represents all other covariates. Then we define the covariate vectors for nondiseased and diseased subjects as X0= (0,X8) and Xi = (1, X*), respectively. The vectors Ao and X1 differ depending on whether we are referring to the location regression, a'X, or the scale regression, P'X However, to simplify notation we assume that when associated with a, Xis a vector of dimension 1xN1 containing covariates included in the location regression and when associated with B, Xis a vector of dimension lxN2 containing covariates included in the scale regression.
The area under the ROC curve, as described by Dorfman and Alf (3), and Swets and Pickett (4) An estimate for the standard error of the difference between two area estimators is obtained analogously.
Description ofModeling Approach
In addition to true disease status, the patient-specific, modality-specific, and external factors described earlier must be induded in our ROC regression. These factors may influence the ROC curves as either main effects or interactions with true disease status. Tosteson and Begg (5) To minimize the complexity of model selection when both location and scale models are available, we developed a general approach in which we first fit true disease status in both location and scale models. True disease status was included in the scale model because of the finding that this term is usually of importance in modeling radiologic data (13) . Next, expanded location models were considered and selection of hierarchical models was completed using the deviance statistic. Using this approach we either included or excluded all indicators for a particular covariate (e.g., primary tumor site would include indicators for three of the four groups). Once location modeling was completed, expanded scale models were considered. Scale modeling was done sparingly because the iterative fitting routine failed to converge for many complicated scale models.
Results of Data Analysis
A total of 502 patients were reviewed during the course of the study, with follow-up pathology available for 326 (65%). Although this raises the concern that verification bias (7, 8) may pose a problem in the analysis, this is unlikely to be a problem because the majority of subjects without disease verification are those entered late in the study. Of those with verified disease status, 165 (51%) have documented liver metastases. The data are comprised of the following mix of primary malignancies: 20% breast, 45% colon, 21% lung, and 14% pancreas (Table 1) .
Empirical and Unadjusted ROC Curves
For the analysis, the 100 point rating scale was collapsed into seven categories (i.e., 0, 1 to 19, 20 to 39, 40 to 59, 60 to 79, 80 to 99, 100). The rating data for MR and CT using this categorization are given in Table  2 . The empirical data points and smoothed curves were fit to these data using Equation 1 (Figure 1 ). We note the apparent similarity between the unadjusted curves. Generally, crossing ROC curves, which are characteristic of models that include interaction terms in the scale model, indicate that no modality is clearly superior.
To answer questions regarding magnet field strength we divide the MR units into three groups: low (0.15 T [teslas] unit), mid (0.35 T, 0.5 T, and 0.6 T units), and high (1.5 T unit). These groups comprise 31, 42, and 27% of the sample, respectively. The empirical data points and curves estimated using Equation 1 for MR at each field strength in comparison to CT The rating data used in our example represented ordinal ratings on a 0-to 100-point scale. In most rating experiments, a more limited set of categories is specified. When reviewers rated the likelihood that metastases were present, however, they tended to use a limited set of values (e.g., 10, 25, 50, etc.) for assigning ratings. To complete the analysis, the reviewers' ratings were grouped into seven response categories. The results of the analysis were unchanged when ratings were collapsed into twelve rather than seven response categories.
Swets and Pickett (4) describe two general approaches to the issue of multiple ratings (more than one review per subject) by different reviewers. The first involves pooling the ratings for each subject and treating them as independent observations. The second involves averaging parameters and summary measures from each reviewer's curve. In contrast, we approach the multiple rating problem by including reviewer effects in the ordinal regression model. The estimation of reviewer effects not only indicated that differences exist between reviewers, but also identified the nature of those differences. The estimated reviewer effects indicated that the decision criteria for the raters were quite different and that some reviewers were better diagnosticians than others, and therefore required us to control all modality comparisons for these important differences.
Our approach to these data, while offering several advantages, also has some limitations. First, our approach does not accommodate the pairing of the data.
Second, the fixed-effects nature of the model used does not allow us to accommodate intrareader correlations. Further work is required before these limitations can be overcome.
Biases in radiologic test assessment are common and have been reviewed by Begg and McNeil (8) . An attempt was made in our study to avoid test interpretation biases by the blinding procedures used in the rating experiment. Biases occurring as a result of disease spectrum, or differences in case mix were partially avoided by adjusting for patient-specific factors in the analysis. These adjustments are more easily made using the ordinal regression model than using standard ROC curve techniques, because of the facility provided by the ordinal regression model for subgroup analyses. As stated previously, we do not expect that verification bias is a serious problem in this analysis.
The potential over-representation of subjects with liver metastases in our data, relative to what would be expected in a population of patients with primary malignancies of the breast, colon, lung, and pancreas, is unlikely to bias our comparison of MR and CT. It does, however, make it likely that estimates of the sensitivity of both modalities in detecting liver metastases are overestimated using any form of ROC curve estimation.
In summary, the ordinal regression model provided a flexible and parsimonious method for analyzing the liver protocol data. The facility that it provides for appropriately adjusting ROC curves for potential confounders and other relevant factors enhances our capacity for carrying out complex comparisons when many factors must be controlled for in the analysis.
